Yüklüyor......
Novel Approaches in Anaplastic Thyroid Cancer Therapy
Anaplastic thyroid cancer (ATC), accounting for less than 2% of all thyroid cancer, is responsible for the majority of death from all thyroid malignancies and has a median survival of 6 months. The resistance of ATC to conventional thyroid cancer therapies, including radioiodine and thyroid-stimulat...
Kaydedildi:
| Yayımlandı: | Oncologist |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AlphaMed Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221369/ https://ncbi.nlm.nih.gov/pubmed/25260367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0182 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|